Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 52 Neoplasms 44 Prostatic Neoplasms 43 Breast Neoplasms 38 Neoplasm Metastasis 21 Unspecified Adult Solid Tumor, Protocol Specific 19 Lung Neoplasms 18 Head and Neck Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 16 Ovarian Neoplasms 15 Advanced Solid Tumors 11 Stomach Neoplasms 9 Sarcoma 9 Pancreatic Neoplasms 9 Solid Tumor 8 Melanoma 8 Esophageal Neoplasms 8 Carcinoma, Ovarian Epithelial 8 Urinary Bladder Neoplasms 7 Fallopian Tube Neoplasms 7 Colorectal Neoplasms 7 Small Cell Lung Carcinoma 6 Salivary Gland Neoplasms 6 Esthesioneuroblastoma, Olfactory 5 Esophageal Squamous Cell Carcinoma 5 Carcinoma, Renal Cell 5 Breast Neoplasms, Male 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Endometrial Neoplasms 4

Interventions

Fulvestrant 4 palbociclib 3 Letrozole 3 Paclitaxel 2 sonidegib 1 ribociclib 1 irinotecan sucrosofate 1 elacestrant 1 XMT-1522 1 Vorinostat 1 Sirolimus 1 Ritonavir 1 Population Groups 1 Itraconazole 1 Immunotherapy, Adoptive 1 Histone Deacetylase Inhibitors 1 FCN-437c 1 Docetaxel 1 Decitabine 1 Dasatinib 1 Combined Modality Therapy 1 Capecitabine 1 CYH33 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Breast Cancer × Docetaxel × Clear all

NCT02027376 2023-04-03

EDALINE

Spanish Breast Cancer Research Group

Phase 1 Completed

12 enrolled 16 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡